Sarah-Jane Dawson
A ctDNA pioneer whose early work showed blood could track breast cancer better than protein markers or imaging.
Sarah-Jane Dawson's studies of circulating tumour DNA in metastatic breast cancer helped launch liquid biopsy as a monitoring tool; her laboratory now develops ctDNA and epigenomic approaches across solid and blood cancers.
| Title | Journal | Year |
|---|---|---|
| Analysis of circulating tumor DNA to monitor metastatic breast cancer | NEJM | 2013 |
Pages like this
not linked directly; found by shared links- IdeaTake the blood test, and give the drug, at the right time of day
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer.
- PersonAsh A. Alizadeh
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- IdeaHPV circulating tumour DNA to guide cervical cancer therapy
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- IdeaCirculating tumour cell clearance as the phase 2 gate for anti-metastatic drugs
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer.
- IdeaBreak the neutrophil DNA nets that catch tumour cells after surgery
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- InstitutionINCLIVA Biomedical Research Institute / Hospital Clínico Universitario de Valencia
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer.
- InstitutionAustralasian Gastro-Intestinal Trials Group
Shares Peter MacCallum Cancer Centre, Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- IdeaUltrasound-assisted blood test instead of a brain biopsy
Shares Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA).